Research ArticleNuclear Oncology
Improved Intratumoral Penetration of Radiolabeled Streptavidin in Intraperitoneal Tumors Pretargeted with Biotinylated Antibody
Meili Zhang, Zhengsheng Yao, Tsuneo Saga, Harumi Sakahara, Yuji Nakamoto, Noriko Sato, Hiroshi Nakada, Ikuo Yamashina and Junji Konishi
Journal of Nuclear Medicine January 1998, 39 (1) 30-33;
Meili Zhang
Zhengsheng Yao
Tsuneo Saga
Harumi Sakahara
Yuji Nakamoto
Noriko Sato
Hiroshi Nakada
Ikuo Yamashina


This is a PDF-only article. The first page of the PDF of this article appears above.
In this issue
Improved Intratumoral Penetration of Radiolabeled Streptavidin in Intraperitoneal Tumors Pretargeted with Biotinylated Antibody
Meili Zhang, Zhengsheng Yao, Tsuneo Saga, Harumi Sakahara, Yuji Nakamoto, Noriko Sato, Hiroshi Nakada, Ikuo Yamashina, Junji Konishi
Journal of Nuclear Medicine Jan 1998, 39 (1) 30-33;
Improved Intratumoral Penetration of Radiolabeled Streptavidin in Intraperitoneal Tumors Pretargeted with Biotinylated Antibody
Meili Zhang, Zhengsheng Yao, Tsuneo Saga, Harumi Sakahara, Yuji Nakamoto, Noriko Sato, Hiroshi Nakada, Ikuo Yamashina, Junji Konishi
Journal of Nuclear Medicine Jan 1998, 39 (1) 30-33;
Jump to section
Related Articles
- No related articles found.
Cited By...
- Intraperitoneal Pretargeted Radioimmunotherapy for Colorectal Peritoneal Carcinomatosis
- Improved Tumor Targeting and Decreased Normal Tissue Accumulation through Extracorporeal Affinity Adsorption in a Two-Step Pretargeting Strategy
- Pretarget radiotherapy with an anti-CD25 antibody-streptavidin fusion protein was effective in therapy of leukemia/lymphoma xenografts
- Pretargeting radioimmunotherapy of a murine model of adult T-cell leukemia with the alpha -emitting radionuclide, bismuth 213